Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Horakova, Dana"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł :
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
Autorzy :
Warrender-Sparkes, Matthew
Spelman, Tim
Izquierdo, Guillermo
Trojano, Maria
Lugaresi, Alessandra
Grand'Maison, François
Havrdova, Eva
Horakova, Dana
Boz, Cavit
Oreja-Guevara, Celia
Alroughani, Raed
Iuliano, Gerardo
Duquette, Pierre
Girard, Marc
Terzi, Murat
Hupperts, Raymond
Grammond, Pierre
Petersen, Thor
Fernandez-Bolanos, Ricardo
Fiol, Marcela
Pucci, Eugenio
Lechner-Scott, Jeannette
Verheul, Freek
Cristiano, Edgardo
Van Pesch, Vincent
Petkovska-Boskova, Tatjana
Moore, Fraser
Kister, Ilya
Bergamaschi, Roberto
Saladino, Maria Laura
Slee, Mark
Barnett, Michael
Amato, Maria Pia
Shaw, Cameron
Shuey, Neil
Young, Carolyn
Gray, Orla
Kappos, Ludwig
Butzkueven, Helmut
Kalincik, Tomas
Jokubaitis, Vilija
MSBase study group
Pokaż więcej
Temat :
Neurology (clinical)
MSBase
Multiple sclerosis
fingolimod
disease-modifying therapy
Journal Article
medication persistence
Research Support, Non-U.S. Gov't
Neurology
Źródło :
Multiple Sclerosis Journal, Vol. 22, no. 4, p. 520-532 (2016)
Warrender-Sparkes, M, Spelman, T, Izquierdo, G, Trojano, M, Lugaresi, A, Grand'Maison, F, Havrdova, E, Horakova, D, Boz, C, Oreja-Guevara, C, Alroughani, R, Iuliano, G, Duquette, P, Girard, M, Terzi, M, Hupperts, R, Grammond, P, Petersen, T, Fernandez-Bolaños, R, Fiol, M, Pucci, E, Lechner-Scott, J, Verheul, F, Cristiano, E, Van Pesch, V, Petkovska-Boskova, T, Moore, F, Kister, I, Bergamaschi, R, Saladino, M L, Slee, M, Barnett, M, Amato, M P, Shaw, C, Shuey, N, Young, C, Gray, O, Kappos, L, Butzkueven, H, Kalincik, T, Jokubaitis, V & MSBase study group 2016, ' The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis ', Multiple sclerosis (Houndmills, Basingstoke, England), vol. 22, no. 4, pp. 520-32 . https://doi.org/10.1177/1352458515594041
Opis pliku :
ELETTRONICO
Tytuł :
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Autorzy :
Le M; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Malpas C; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Sharmin S; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Horáková D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Eichau S; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Ozakbas S; Dokuz Eylul University, Konak/Izmir, Turkey.
Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Prat A; Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, QC, Canada.
Girard M; Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, QC, Canada.
Duquette P; Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, QC, Canada.
Larochelle C; Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, QC, Canada.
Alroughani R; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
Bergamaschi R; IRCCS Mondino Foundation, Pavia, Italy.
Sola P; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
Ferraro D; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
Grammond P; CISSS de Chaudière-Appalache, Levis, QC, Canada.
Grand' Maison F; Neuro Rive-Sud, Quebec, QC, Canada.
Terzi M; Faculty of Medicine, 19 Mayis University, Samsun, Turkey.
Boz C; Farabi Hospital, KTU Faculty of Medicine, Trabzon, Turkey.
Hupperts R; Zuyderland Ziekenhuis, Sittard, Netherlands.
Butzkueven H; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Pucci E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy.
Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
Yamout BI; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
Lechner-Scott J; School of Medicine and Public Health, The University of Newcastle Australia, Newcastle, NSW, Australia.
Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati - Avellino, Avellino, Italy.
Ampapa R; Nemocnice Jihlava, Jihlava, Czech Republic.
Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Ramo-Tello C; Hospital Germans Trias i Pujol, Barcelona, Spain.
Sanchez-Menoyo JL; Hospital de Galdakao-Usansolo, Galdakao, Spain.
Sidhom Y; Department of Neurology, Razi Hospital, Manouba, Tunisia.
Gouider R; Department of Neurology, Razi Hospital, Manouba, Tunisia.
Shaygannejad V; Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of.
Prevost J; CSSS Saint-Jérôme, Saint-Jerome, QC, Canada.
Altintas A; School of Medicine, Koc University, Istanbul, Turkey.
Fragoso YD; Universidade Metropolitana de Santos, Santos, Brazil.
McCombe PA; The University of Queensland, Brisbane, QLD, Australia.
Petersen T; Kommunehospitalet, Arhus C, Denmark.
Slee M; Flinders University, Adelaide, SA, Australia.
Barnett MH; Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.
Vucic S; Westmead Hospital, Sydney, NSW, Australia.
Van Der Walt A; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Kalincik T; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Apr; Vol. 27 (5), pp. 755-766. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Autorzy :
Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
McComb M; Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Galkin S; Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Srpova B; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Oechtering J; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Barro C; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Bergsland N; Buffalo Neuroimaging Analysis Center, Department of Neurology, University at Buffalo, The State University of New York, Buffalo, NY, USA/IRCCS, Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Krasensky J; Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Dwyer M; Buffalo Neuroimaging Analysis Center, Department of Neurology, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Posova H; Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Vaneckova M; Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, University at Buffalo, The State University of New York, Buffalo, NY, USA/Center for Biomedical Imaging, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Kuhle J; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Ramanathan M; Department of Pharmaceutical Sciences, The State University of New York, Buffalo, NY, USA/Department of Neurology, The State University of New York, Buffalo, NY, USA.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Feb; Vol. 27 (2), pp. 220-231. Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Determinants of therapeutic lag in multiple sclerosis.
Autorzy :
Roos I; CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Leray E; Rennes University, EHESP, REPERES - EA 7449, Rennes, France/Rennes University, CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)], Rennes, France.
Frascoli F; Faculty of Science, Engineering and Technology, School of Science, Department of Mathematics, Swinburne University of Technology, Melbourne, VIC, Australia.
Casey R; Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France/Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, France/Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, France/EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis, State-Approved Foundation, Bron, France.
Brown JWL; CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
Debouverie M; Department of Neurology, Nancy University Hospital, Nancy, France/Université de Lorraine, APEMAC, Nancy, France.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Patti F; GF Ingrassia Department, University of Catania, Catania, Italy/Policlinico G Rodolico, Catania, Italy.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Eichau S; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Edan G; Centre hospitalier universitaire de Rennes, Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM, Rennes, France.
Prat A; CHUM MS Center and Universite de Montreal, Montreal, QC, Canada.
Girard M; CHUM MS Center and Universite de Montreal, Montreal, QC, Canada.
Duquette P; CHUM MS Center and Universite de Montreal, Montreal, QC, Canada.
Onofrj M; Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy.
Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italia.
Grammond P; CISSS Chaudière-Appalache, Lévis, QC, Canada.
Ciron J; Hôpital Pierre-Paul Riquet, Department of Neurology, CHU de Toulouse, CRC-SEP, Toulouse, France.
Ruet A; University Bordeaux, Bordeaux, France/INSERM U1215, Neurocentre Magendie, Bordeaux, France/Department of Neurology, CHU de Bordeaux, CIC Bordeaux CIC1401, Bordeaux, France.
Ozakbas S; Dokuz Eylul University, Konak/Izmir, Turkey.
De Seze J; CHU de Strasbourg, Department of Neurology and Clinical Investigation Center, CIC (centre d'investigation clinique) INSERM 1434, Strasbourg, France.
Louapre C; Sorbonne Université, Institut du Cerveau, ICM, Assistance Publique Hôpitaux de Paris APHP, Département de neurologie, Hôpital de la Pitié Salpêtrière, Paris, France.
Zephir H; CHU Lille, CRCSEP Lille, Univ Lille, U1172, Lille, France.
Sá MJ; Centro Hospitalar Universitário de São João and Universidade Fernando Pessoa, Porto, Portugal.
Sola P; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
Ferraro D; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
Labauge P; CHU de Montpellier, MS Unit, Montpellier, France/University of Montpellier (MUSE), Montpellier, France.
Defer G; CHU de Caen, MS Expert Centre, Department of Neurology, avenue de la Côte-de-Nacre, Normandy University, Caen, France.
Bergamaschi R; IRCCS Mondino Foundation, Pavia, Italy.
Lebrun-Frenay C; CRCSEP Nice, UR2CA, Université Nice Cote d'Azur, Centre hospitalier universitaire de Nice, Hopital Pasteur 2, Nice, France.
Boz C; KTU Medical Faculty Farabi Hospital, Trabzon, Turkey.
Cartechini E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche - AV3, Macerata, Italy.
Moreau T; CHU de Dijon, Department of Neurology, EA4184, Dijon, France.
Laplaud D; CHU de Nantes, Service de Neurologie & CIC015 INSERM, Nantes, France/CRTI-Inserm U1064, Nantes, France.
Lechner-Scott J; School of Medicine and Public Health, University Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
Grand'Maison F; Neuro Rive-Sud, Quebec, QC, Canada.
Gerlach O; Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
Terzi M; Medical Faculty, 19 Mayis University, Samsun, Turkey.
Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy/Department of General Medicine, Parma University Hospital, Parma, Italy.
Alroughani R; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Van Pesch V; Cliniques universitaires Saint-Luc, UCLouvain, Bruxelles, Belgium.
Van Wijmeersch B; Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium.
Spitaleri D; Neurological Unit AORN San G. Moscati, Avellino, Italy.
Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
Berger E; CHU de Besançon, Department of Neurology, Besançon, France.
Prevost J; CSSS Saint-Jérôme, Saint-Jerome, QC, Canada.
Aguera-Morales E; Hospital Universitario Reina Sofia Cordoba (IMIBIC), Cordoba, Spain.
McCombe P; University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Castillo Triviño T; Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastian, Spain.
Clavelou P; CHU Clermont-Ferrand, Department of Neurology, Clermont-Ferrand, France/Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France.
Pelletier J; Aix Marseille Univ, APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, Marseille, France.
Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Stankoff B; Sorbonne Universités, UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de la Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, Pars, France/Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France.
Gout O; Fondation Adolphe de Rothschild de l'œil et du cerveau, Department of Neurology, Paris, France.
Thouvenot E; CHU de Nîmes, Department of Neurology, Nîmes, France/Institut de Génomique Fonctionnelle, UMR5203, INSERM 1191, Université de Montpellier, Montpellier, France.
Heinzlef O; Centre hospitalier intercommunal de Poissy Saint-Germain-en-Laye, Departement of Neurology, Poissy, France.
Sidhom Y; Department of Neurology - LR 18 SP03 - CIC Neurosciences, Razi Hospital, La Manouba, Tunisia.
Gouider R; Department of Neurology - LR 18 SP03 - CIC Neurosciences, Razi Hospital, La Manouba, Tunisia/Faculty of Medicine, UTM, Tunis, Tunisia.
Csepany T; Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Bourre B; Centre hospitalier universitaire Rouen Normandie, Hôpital Charles-Nicolle, Departement of Neurology, Rouen, France.
Al Khedr A; Amiens University Hospital, Department of Neurology, place Victor Pauchet, Amiens, France.
Casez O; Department of Neurology, Centre hospitalier universitaire Grenoble-Alpes, La Tronche/Grenoble, France.
Cabre P; Centre hospitalier universitaire de Martinique, Department of Neurology, Hôpital Pierre Zobda-Quitman, Fort-de-France, France.
Montcuquet A; Centre hospitalier universitaire Limoges, Department of Neurology, Hôpital Dupuytren, Limoges, France.
Wahab A; Assistance publique des hôpitaux de Paris, Department of Neurology, Hôpital Henri Mondor, Créteil, France.
Camdessanche JP; Centre hospitalier universitaire de Saint-Étienne, Department of Neurology, Hôpital Nord, Saint-Étienne, France.
Maurousset A; Centre hospitalier régional universitaire de Tours, Department of Neurology, Hôpital Bretonneau, CRCSEP, Tours, France.
Patry I; Department of Neurology, Centre Hospitalier Sud Francilien, Corbeil Essonnes, France.
Hankiewicz K; Department of Neurology, Hôpital Pierre Delafontaine, Centre Hospitalier de Saint-Denis, Saint-Denis, France.
Pottier C; Department of Neurology, Centre hospitalier de Pontoise, Hôpital René Dubos, Pontoise, France.
Maubeuge N; CHU La Milétrie, Hôpital Jean Bernard, Department of Neurology, Poitiers, France.
Labeyrie C; Assistance publique des hôpitaux de Paris, Hôpital Bicêtre, Department of Neurology, Le Kremlin Bicêtre, France.
Nifle C; Hopital Andre Mignot, Department of Neurology, 177 Rue de Versailles, Le Chesnay, France.
Coles A; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Malpas CB; CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Vukusic S; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon/Bron, France/Centre des Neurosciences de Lyon, Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, Lyon, France/Université Claude Bernard Lyon 1, Faculté de médecine Lyon Est, Lyon, France.
Butzkueven H; Central Clinical School, Monash University, Melbourne, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Monash University, Melbourne, VIC, Australia.
Kalincik T; CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Jan 11, pp. 1352458520981300. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis.
Autorzy :
Srpova B; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Uher T; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Hrnciarova T; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Barro C; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Andelova M; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Michalak Z; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Vaneckova M; Department of Radiology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Krasensky J; Department of Radiology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Noskova L; Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Kuhle J; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Jan; Vol. 27 (1), pp. 52-60. Date of Electronic Publication: 2020 Jan 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Autorzy :
Fambiatos A; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Jokubaitis V; Central Clinical School, Monash University, Melbourne, VIC, Australia The Alfred, Melbourne, VIC, Australia.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Kubala Havrdova E; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Prat A; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
Girard M; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
Duquette P; Hopital Notre-Dame, Montreal, QC, Canada/CHUM and Universite de Montreal, Montreal, QC, Canada.
Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Grand'Maison F; Neuro-Rive-Sud, Greenfield Park, QC, Canada.
Grammond P; CISSS de Chaudière-Appalache, Centre-Hospitalier, Levis, Canada.
Sola P; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
Ferraro D; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
Terzi M; Medical Faculty, Ondokuz Mayis University, Samsun, Turkey.
Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
Boz C; TU Medical Faculty, Farabi Hospital, Karadeniz Technical University, Trabzon, Turkey.
Lechner-Scott J; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia.
Pucci E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche, Macerata, Italy.
Bergamaschi R; IRCCS Mondino Foundation, Pavia, Italy.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Ozakbas S; Dokuz Eylul University, Izmir, Turkey.
Granella F; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati - Avellino, Avellino, Italy.
McCombe P; The University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Solaro C; Ospedale P.A. Micone, Genova, Italy.
Slee M; Flinders University, Adelaide, SA, Australia.
Ampapa R; Nemocnice Jihlava, Jihlava, Czech Republic.
Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
Petersen T; Kommunehospitalet, Arhus, Denmark.
Sanchez-Menoyo JL; Hospital de Galdakao-Usansolo, Galdakao, Spain.
Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
Prevost J; CSSS Saint-Jérôme, Saint-Jerome, QC, Canada.
Sidhom Y; Department of Neurology, Razi Hospital, Manouba, Tunisia.
Van Wijmeersch B; Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium.
Vucic S; Westmead Hospital, Sydney, NSW, Australia.
Cristiano E; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Saladino ML; Institute of Neurosciences Buenos Aires, Buenos Aires, Argentina.
Deri N; Hospital Fernandez, Buenos Aires, Argentina.
Barnett M; Brain and Mind Centre, Sydney, NSW, Australia.
Olascoaga J; Hospital Universitario Donostia-Instituto de Investigación Sanitaria Biodonostia, San Sebastian, Spain.
Moore F; Jewish General Hospital, Montreal, QC, Canada.
Skibina O; The Alfred, Melbourne, VIC, Australia.
Gray O; South East Trust, Belfast, UK.
Fragoso Y; Universidade Metropolitana de Santos, Santos, Brazil.
Yamout B; American University of Beirut Medical Center, Beirut, Lebanon.
Shaw C; Geelong Hospital, Geelong, VIC, Australia.
Singhal B; Bombay Hospital Institute of Medical Sciences, Mumbai, India.
Shuey N; St Vincent's Hospital, Melbourne, VIC, Australia.
Hodgkinson S; Liverpool Hospital, Sydney, NSW, Australia.
Altintas A; Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.
Al-Harbi T; King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Csepany T; Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Taylor B; Royal Hobart Hospital, Hobart, TAS, Australia.
Hughes J; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Jun JK; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
van der Walt A; Central Clinical School, Monash University, Melbourne, VIC, Australia The Alfred, Melbourne, VIC, Australia.
Spelman T; Central Clinical School, Monash University, Melbourne, VIC, Australia.
Butzkueven H; Central Clinical School, Monash University, Melbourne, VIC, Australia/The Alfred, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Melbourne, VIC, Australia.
Kalincik T; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia/L4 Centre, Melbourne Brain Centre at Royal Melbourne Hospital, Parkville, VIC, Australia.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2020 Jan; Vol. 26 (1), pp. 79-90. Date of Electronic Publication: 2019 Aug 09.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Progression*
Severity of Illness Index*
Immunologic Factors/*pharmacology
Multiple Sclerosis, Chronic Progressive/*epidemiology
Multiple Sclerosis, Relapsing-Remitting/*epidemiology
Adult ; Female ; Humans ; Longitudinal Studies ; Male ; Multiple Sclerosis, Chronic Progressive/drug therapy ; Multiple Sclerosis, Chronic Progressive/physiopathology ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Risk
Czasopismo naukowe
Tytuł :
International consensus on quality standards for brain health-focused care in multiple sclerosis.
Autorzy :
Hobart J; Plymouth University Peninsula Schools of Medicine and Dentistry, University of Plymouth, Plymouth, UK.
Bowen A; NHS RightCare, NHS England, London, UK.
Pepper G; Shift.ms, Leeds, UK.
Crofts H; PharmaGenesis London, London, UK.
Eberhard L; PharmaGenesis London, London, UK.
Berger T; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Boyko A; Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, Moscow, Russia/Demyelinating Diseases Center, Yusupov Hospital, Moscow, Russia.
Boz C; Department of Neurology, Karadeniz Technical University, Trabzon, Turkey.
Butzkueven H; MS and Neuroimmunology Unit, Alfred Health and Eastern Health, Monash University, Melbourne, VIC, Australia.
Celius EG; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Drulovic J; Department for Immune-Mediated Disorders of the Central Nervous System, Clinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Flores J; National Institute of Neurology and Neurosurgery, ABC Medical Center, Mexico City, Mexico.
Horáková D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Lebrun-Frénay C; CRCSEP Neurologie Pasteur 2, Université Côte d'Azur, Nice, France.
Marrie RA; Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Overell J; Glasgow MS Clinical Research Centre, Queen Elizabeth University Hospital, Glasgow, UK.
Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Rasmussen PV; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Sá MJ; MS Clinic, Department of Neurology, Centro Hospitalar São João, Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal.
Sîrbu CA; Clinic of Neurology, Central Military Emergency University Hospital, Bucharest, Romania.
Skromne E; Instituto Mexicano de Neurociencias, Hospital Angeles Lomas, Mexico City, Mexico.
Torkildsen Ø; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
van Pesch V; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Vollmer T; Department of Neurology, University of Colorado, Denver, CO, USA.
Zakaria M; Department of Neurology, Ain Shams University, Cairo, Egypt.
Ziemssen T; Department of Neurology, MS Center Dresden, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Giovannoni G; Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2019 Nov; Vol. 25 (13), pp. 1809-1818. Date of Electronic Publication: 2018 Nov 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain*/pathology
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/pathology
Multiple Sclerosis*/therapy
Neurology/*standards
Consensus ; Delphi Technique ; Humans
Czasopismo naukowe
Tytuł :
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
Autorzy :
Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Vaneckova M; Department of Radiodiagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Krasensky J; Department of Radiodiagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Sobisek L; Department of Statistics and Probability, University of Economics-Prague, Prague, Czech Republic.
Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Volna J; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Seidl Z; Department of Radiodiagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Bergsland N; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/IRCCS 'S. Maria Nascente', Don Carlo Gnocchi Foundation, Milan, Italy.
Dwyer MG; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/Translational Imaging Center, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, NY, USA.
De Stefano N; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Sormani MP; Department of Health Science, University of Genoa, Genoa, Italy.
Havrdova EK; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2019 Apr; Vol. 25 (4), pp. 541-553. Date of Electronic Publication: 2017 Nov 16.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Progression*
Brain/*pathology
Multiple Sclerosis/*diagnosis
Multiple Sclerosis/*pathology
Adolescent ; Adult ; Aged ; Atrophy/pathology ; Brain/diagnostic imaging ; Corpus Callosum/diagnostic imaging ; Corpus Callosum/pathology ; Female ; Gray Matter/diagnostic imaging ; Gray Matter/pathology ; Humans ; Longitudinal Studies ; Magnetic Resonance Imaging/standards ; Male ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Sensitivity and Specificity ; Thalamus/diagnostic imaging ; Thalamus/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
Autorzy :
Kalincik T; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
Jokubaitis V; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Spelman T; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Lechner-Scott J; The University of Newcastle, Newcastle, NSW, Australia.
Lugaresi A; Department of Neuroscience, Imaging and Clinical Sciences, University 'G. d'Annunzio', Chieti, Italy/ Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy/IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Prat A; Hôpital Notre-Dame, Montreal, QC, Canada/CHUM, Universite de Montreal, Montreal, QC, Canada.
Girard M; Hôpital Notre-Dame, Montreal, QC, Canada/CHUM, Universite de Montreal, Montreal, QC, Canada.
Duquette P; Hôpital Notre-Dame, Montreal, QC, Canada/CHUM, Universite de Montreal, Montreal, QC, Canada.
Grammond P; CISSS de Chaudière-Appalache, Levis, QC, Canada.
Solaro C; Ospedale Padre Antero Micone, Genoa, Italy.
Grand'Maison F; Clinique Neuro Rive-Sud, Greenfield Park, QC, Canada.
Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
Prevost J; CSSS de Saint-Jérôme, Saint-Jerome, QC, Canada.
Sola P; Nuovo Ospedale Civile Sant'Agostino-Estense, Modena, Italy.
Ferraro D; Nuovo Ospedale Civile Sant'Agostino-Estense, Modena, Italy.
Terzi M; Medical Faculty, 19 Mayis University, Samsun, Turkey.
Butler E; Monash Medical Centre, Melbourne, VIC, Australia.
Slee M; Flinders University, Adelaide, SA, Australia.
Kermode A; The Perron Institute, The University of Western Australia, Perth, WA, Australia/Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Fabis-Pedrini M; The Perron Institute, The University of Western Australia, Perth, WA, Australia.
McCombe P; The University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Barnett M; Brain and Mind Centre, Sydney, NSW, Australia.
Shaw C; Geelong Hospital, Geelong, VIC, Australia.
Hodgkinson S; Liverpool Hospital, Sydney, NSW, Australia.
Butzkueven H; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia/Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Corporate Authors :
MSBase Study Group
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2018 Oct; Vol. 24 (12), pp. 1617-1626. Date of Electronic Publication: 2017 Aug 31.
Typ publikacji :
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cladribine/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Adult ; Cohort Studies ; Female ; Fingolimod Hydrochloride/therapeutic use ; Humans ; Interferon-beta/therapeutic use ; Male ; Middle Aged ; Natalizumab/therapeutic use ; Propensity Score ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
Autorzy :
Signori A; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, Genova, Italy.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Lugaresi A; Department of Biomedical and Neuromotor Sciences(DIBINEM), Alma Mater Studiorum, University of Bologna, Italy/IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
Grand'Maison F; Clinique Neuro Rive-Sud, Greenfield Park, QC, Canada.
Sola P; Nuovo Ospedale Civile S. Agostino-Estense, Modena, Italy.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Prat A; Hôpital Notre-Dame, Montreal, QC, Canada.
Girard M; Hôpital Notre-Dame, Montreal, QC, Canada.
Duquette P; Hôpital Notre-Dame, Montreal, QC, Canada.
Boz C; KTU Medical Faculty Farabi Hospital, Trabzon, Turkey.
Grammond P; Centre de Réadaptation En Déficience Physique Chaudière-Appalache, Levis, QC, Canada.
Terzi M; Medical Faculty, Ondokuz Mayis University, Samsun, Turkey.
Singhal B; Bombay Hospital Institute of Medical Sciences (BHIMS), Mumbai, India.
Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
Petersen T; Kommunehospitalet, Aarhus, Denmark.
Ramo C; Hospital Germans Trias i Pujol, Badalona, Spain.
Oreja-Guevara C; Hospital Clinico San Carlos, Madrid, Spain.
Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati, Avellino, Italy.
Shaygannejad V; Isfahan University of Medical Sciences, Isfahan, Iran.
Butzkueven H; Box Hill Hospital, Melbourne, VIC, Australia/Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Kalincik T; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Jokubaitis V; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Slee M; Flinders University and Medical Centre, Adelaide, SA, Australia.
Fernandez Bolaños R; Hospital Universitario Virgen de Valme, Seville, Spain.
Sanchez-Menoyo JL; Hospital de Galdakao-Usansolo, Galdakao, Spain.
Pucci E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche, Macerata, Italy.
Granella F; University of Parma, Parma, Italy.
Lechner-Scott J; Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Hughes S; Craigavon Area Hospital, Craigavon, UK.
Bergamaschi R; C. Mondino National Neurological Institute, Pavia, Italy.
Taylor B; Royal Hobart Hospital, Hobart, TAS, Australia.
Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
Edite Rio M; Hospital São João, Porto, Portugal.
Amato MP; Department NEUROFARBA, Section Neuroscience, University of Florence, Florence, Italy.
Sajedi SA; Department of Neurology, Golestan University of Medical Sciences, Gorgan, Iran/Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Majdinasab N; Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Sormani MP; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, Genova, Italy.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2018 Apr; Vol. 24 (5), pp. 642-652. Date of Electronic Publication: 2017 Apr 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disability Evaluation*
Disease Progression*
Latent Class Analysis*
Registries*
Multiple Sclerosis, Chronic Progressive/*pathology
Adult ; Age Factors ; Bayes Theorem ; Delayed Diagnosis ; Disabled Persons ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Multiple Sclerosis, Chronic Progressive/diagnosis ; Prognosis ; Prospective Studies ; Sex Factors
Czasopismo naukowe
Tytuł :
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
Autorzy :
Spelman T; Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Meyniel C; Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.; Department of Neurophysiologie, Pitié-Salpêtrière Hospital, Paris, France.
Rojas JI; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Lugaresi A; MS Center, Department of Neuroscience and Imaging, University 'G. d'Annunzio', Chieti, Italy.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Grand'Maison F; Neuro Rive-Sud, Hôpital Charles LeMoyne, Greenfield Park, QC, Canada.
Boz C; Karadeniz Technical University, Trabzon, Turkey.
Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Duquette P; Hôpital Notre-Dame, Montreal, QC, Canada.
Terzi M; Ondokuz Mayis University, Samsun, Turkey.
Grammond P; Centre de réadaptation en déficience physique Chaudière-Appalaches, Levis, QC, Canada.
Hupperts R; Maaslandziekenhuis, Sittard, The Netherlands.
Lechner-Scott J; John Hunter Hospital, Newcastle, NSW, Australia.
Oreja-Guevara C; Hospital Clínico San Carlos, Madrid, Spain.
Pucci E; Neurology Unit, ASUR Marche - AV3, Macerata, Italy.
Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
Fiol M; Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Buenos Aires, Argentina.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Cristiano E; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Petersen T; Kommunehospitalet, Aarhus, Denmark.
Moore F; Jewish General Hospital, Montreal, QC, Canada.
Kalincik T; Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Jokubaitis V; Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Butzkueven H; Department of Neurology, Box Hill hospital, Monash University, Box Hill, VIC, Australia.
Pokaż więcej
Corporate Authors :
MSBasis (an MSBase Substudy) Investigators
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2017 Sep; Vol. 23 (10), pp. 1346-1357. Date of Electronic Publication: 2016 Nov 25.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Nomograms*
Demyelinating Diseases/*pathology
Adult ; Age of Onset ; Demyelinating Diseases/drug therapy ; Disease Progression ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Multiple Sclerosis/pathology ; Prognosis ; Proportional Hazards Models ; Recurrence ; Risk Factors
Czasopismo naukowe
Tytuł :
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Autorzy :
Stewart T; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Spelman T; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, Parkville, VIC, Australia.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University in Prague, Prague, Czech Republic.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Duquette P; Hôpital Notre Dame, CHUM and Université de Montréal, Montreal, QC, Canada.
Girard M; Hôpital Notre Dame, CHUM and Université de Montréal, Montreal, QC, Canada.
Prat A; Hôpital Notre Dame, CHUM and Université de Montréal, Montreal, QC, Canada.
Lugaresi A; MS Centre, Department of Neuroscience, Imaging and Clinical Sciences, 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
Grand'Maison F; Neuro Rive-Sud, Hôpital Charles LeMoyne, Greenfield Park, QC, Canada.
Grammond P; Hôtel-Dieu de Lévis, Levis, QC, Canada.
Sola P; Neurology Unit, Department of Neuroscience, Nuovo Ospedale Civile S. Agostino-Estense, Modena, Italy.
Shaygannejad V; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
Alroughani R; Department of Neurology, Amiri Hospital, Kuwait City, Kuwait.
Oreja-Guevara C; University Hospital San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Pucci E; Neurology Unit, ASUR Marche AV3, Macerata, Italy.
Boz C; Karadeniz Technical University, Trabzon, Turkey.
Lechner-Scott J; Hunter Medical Research Institute, The University of Newcastle Australia, Callaghan, NSW, Australia.
Bergamaschi R; C. Mondino National Neurological Institute, Pavia, Italy.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Ramo C; Hospital Germans Trias i Pujol, Badalona, Spain.
Taylor B; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Slee M; Flinders University and Medical Centre, Adelaide, SA, Australia.
Spitaleri D; AORN San Giuseppe Moscati, Avellino, Italy.
Granella F; University of Parma, Parma, Italy.
Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
McCombe P; Centre for Clinical Research, The University of Queensland Australia, Brisbane, QLD, Australia.
Hodgkinson S; Departments of Nephrology and Neurology, Liverpool Hospital, Liverpool, NSW, Australia.
Amato MP; Section of Neurosciences, NEUROFARBA, University of Florence, Florence, Italy.
Vucic S; Westmead Hospital, Sydney, NSW, Australia.
Gray O; Craigavon Area Hospital, Portadown, UK.
Cristiano E; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Barnett M; Brain and Mind Centre, Camperdown, NSW, Australia.
Sanchez Menoyo JL; Department of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Spain.
van Munster E; Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.
Saladino ML; Ineba, Buenos Aires, Argentina.
Olascoaga J; Department of Neurology, Donostia University Hospital, San Sebastian, Spain.
Prevost J; Centre Intégré de Santé et de Services Sociaux des Laurentides, Saint-Jerome, QC, Canada.
Deri N; Hospital Fernandez, Buenos Aires, Argentina.
Shaw C; Geelong Hospital, Geelong, VIC, Australia.
Singhal B; Bombay Hospital Institute of Medical Sciences, Mumbai, India.
Moore F; Jewish General Hospital, Montreal, QC, Canada.
Rozsa C; Jahn Ferenc Teaching Hospital, Budapest, Hungary.
Shuey N; St Vincent's Hospital, Melbourne, Melbourne, VIC, Australia.
Skibina O; The Alfred Hospital, Melbourne, VIC, Australia.
Kister I; Department of Neurology, NYU School of Medicine, New York, NY, USA.
Petkovska-Boskova T; Clinical Neurology Clinical Center, Skopje, Macedonia.
Ampapa R; Nemocnice Jihlava, Jihlava, Czech Republic.
Kermode A; Western Australian Neuroscience Research Institute, The University of Western Australia, Perth, WA, Australia/Institute of Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Butzkueven H; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, Parkville, VIC, Australia/Department of Neurology, Box Hill Hospital, Monash University, Melbourne, VIC, Australia.
Jokubaitis V; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, Parkville, VIC, Australia.
Kalincik T; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, Parkville, VIC, Australia.
Pokaż więcej
Corporate Authors :
MSBase Study Group
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2017 Feb; Vol. 23 (2), pp. 266-276. Date of Electronic Publication: 2016 Jul 11.
Typ publikacji :
Journal Article
MeSH Terms :
Recurrence*
Disabled Persons/*statistics & numerical data
Interferon-beta/*therapeutic use
Multiple Sclerosis/*drug therapy
Adult ; Chronic Disease ; Disability Evaluation ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/physiopathology ; Prospective Studies
Czasopismo naukowe
Tytuł :
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
Autorzy :
Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Sobisek L; Department of Statistics and Probability, University of Economics in Prague, Prague, Czech Republic.
Krasensky J; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Vaneckova M; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Seidl Z; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Ramasamy D; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/MR Imaging Clinical Translational Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2017 Feb; Vol. 23 (2), pp. 242-252. Date of Electronic Publication: 2016 Jul 11.
Typ publikacji :
Journal Article
MeSH Terms :
Interferon beta-1a/*therapeutic use
Interferon-beta/*therapeutic use
Multiple Sclerosis/*drug therapy
Adolescent ; Adult ; Disease Progression ; Female ; Follow-Up Studies ; Goals ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Multiple Sclerosis/pathology ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
Autorzy :
Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Vaneckova M; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Sobisek L; Department of Statistics and Probability, University of Economics, Prague, Czech Republic.
Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Seidl Z; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Krasensky J; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Ramasamy D; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA/MR Imaging Clinical Translational Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Kalincik T; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2017 Jan; Vol. 23 (1), pp. 51-61. Date of Electronic Publication: 2016 Jul 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Magnetic Resonance Imaging*/methods
Multiple Sclerosis/*diagnostic imaging
Adult ; Atrophy ; Biomarkers/analysis ; Brain/diagnostic imaging ; Disability Evaluation ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Interferon beta-1a/therapeutic use ; Male ; Middle Aged ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/pathology ; Predictive Value of Tests
Czasopismo naukowe
Tytuł :
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
Autorzy :
Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/MR Imaging Clinical Translational Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA .
Uher T; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Hagemeier J; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Vaneckova M; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Ramasamy DP; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Bergsland N; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/IRCCS 'S. Maria Nascente,' Don Carlo Gnocchi Foundation, Milan, Italy.
Seidl Z; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Dwyer MG; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Krasensky J; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2016 Nov; Vol. 22 (13), pp. 1709-1718. Date of Electronic Publication: 2016 Feb 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Progression*
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Multiple Sclerosis, Relapsing-Remitting*/physiopathology
Brain/*pathology
Cerebral Ventricles/*pathology
Gray Matter/*pathology
White Matter/*pathology
Adult ; Atrophy/pathology ; Brain/diagnostic imaging ; Cerebral Ventricles/diagnostic imaging ; Female ; Follow-Up Studies ; Gray Matter/diagnostic imaging ; Humans ; Magnetic Resonance Imaging ; Male ; White Matter/diagnostic imaging
Czasopismo naukowe
Tytuł :
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Autorzy :
Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic/Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Zeman D; Department of Neurology, University Hospital, Ostrava, Czech Republic.
Krasulova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Mrazova K; Department of Clinical Biochemistry, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Seidl Z; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Vaneckova M; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Krasensky J; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Weinstock-Guttman B; Department of Neurology, State University of New York, Buffalo, NY, USA.
Ramanathan M; Department of Neurology, State University of New York, Buffalo, NY, USA/Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA/MR Imaging Clinical Translational Research Center, State University of New York, Buffalo, NY, USA .
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2016 May; Vol. 22 (6), pp. 770-81. Date of Electronic Publication: 2015 Sep 11.
Typ publikacji :
Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood-Brain Barrier*
Disease Progression*
Severity of Illness Index*
Albumins/*cerebrospinal fluid
Brain/*pathology
Multiple Sclerosis/*cerebrospinal fluid
Multiple Sclerosis/*physiopathology
Adult ; Atrophy/pathology ; Biomarkers ; Brain/diagnostic imaging ; Female ; Follow-Up Studies ; Humans ; Male ; Multiple Sclerosis/blood ; Serum Albumin ; Young Adult
Czasopismo naukowe
Tytuł :
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Autorzy :
Warrender-Sparkes M; Department of Medicine, University of Melbourne, Melbourne, Australia.
Spelman T; Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.
Lugaresi A; MS Center, Department of Neuroscience, Imaging and Clinical Sciences, University 'G. d'Annunzio', Chieti, Italy.
Grand'Maison F; Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
Boz C; Karadeniz Technical University, Trabzon, Turkey.
Oreja-Guevara C; University Hospital San Carlos, IdISSC, Madrid, Spain.
Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Duquette P; Hôpital Notre-Dame, Montreal, Canada.
Girard M; Hôpital Notre-Dame, Montreal, Canada.
Terzi M; Ondokuz Mayis Üniversitesi, Samsun, Turkey.
Hupperts R; Orbis Medicle Center, Sittard, The Netherlands.
Grammond P; Hotel-Dieu de Levis, Quebec, Canada.
Petersen T; Aarhus University Hospital, Aarhus C, Denmark.
Fernandez-Bolaños R; Hospital Universitario Virgen de Valme, Seville, Spain.
Fiol M; FLENI, Buenos Aires, Argentina.
Pucci E; Ospedale di Macerata, Macerata, Italy.
Lechner-Scott J; John Hunter Hospital, Newcastle, Australia.
Verheul F; Groen Hart Ziekenhuis, Gouda, The Netherlands.
Cristiano E; Hospital Italiano, Buenos Aires, Argentina.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Petkovska-Boskova T; Neurology Clinical Center, Skopje, Macedonia.
Moore F; Jewish General Hospital, Montreal, Canada.
Kister I; New York University Langone Medical Center, New York, USA.
Bergamaschi R; National Neurological Institute C. Mondino, Pavia, Italy.
Saladino ML; INEBA, Buenos Aires, Argentina.
Slee M; Flinders University and Medical Centre, Adelaide, Australia.
Barnett M; Brain and Mind Research Institute, Sydney, Australia.
Amato MP; Department NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Shaw C; Geelong Hospital, Geelong, Australia.
Shuey N; St Vincent's Hospital, Melbourne, Australia.
Young C; The Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom.
Gray O; Craigavon Area Hospital, Portadown, United Kingdom.
Kappos L; University Hospital Basel, Neurology, Departments of Medicine, Clinical Research and Biomedicine, Basel, Switzerland.
Butzkueven H; Department of Medicine, University of Melbourne, Melbourne, Australia/ Department of Neurology, Box Hill Hospital, Monash University, Box Hill, Australia.
Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Australia/Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
Jokubaitis V; Department of Medicine, University of Melbourne, Melbourne, Australia .
Pokaż więcej
Corporate Authors :
MSBase study group
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2016 Apr; Vol. 22 (4), pp. 520-32. Date of Electronic Publication: 2015 Jul 21.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Substitution*
Medication Adherence*
Demyelinating Diseases/*drug therapy
Fingolimod Hydrochloride/*administration & dosage
Immunosuppressive Agents/*administration & dosage
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Administration, Oral ; Adult ; Aged ; Demyelinating Diseases/diagnosis ; Demyelinating Diseases/immunology ; Female ; Fingolimod Hydrochloride/adverse effects ; Humans ; Immunosuppressive Agents/adverse effects ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Multivariate Analysis ; Proportional Hazards Models ; Prospective Studies ; Registries ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Autorzy :
Kalincik T; Department of Medicine, University of Melbourne, Melbourne, Australia and Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia .
Jokubaitis V; Department of Medicine, University of Melbourne, Melbourne, Australia and Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
Duquette P; Hôpital Notre Dame, Montreal, Canada.
Girard M; Hôpital Notre Dame, Montreal, Canada.
Grammond P; Hotel-Dieu de Levis, Quebec, Canada.
Lugaresi A; MS Center, Neuroscience, Imaging and Clinical Sciences, University 'G. d'Annunzio', Chieti, Italy.
Oreja-Guevara C; University Hospital San Carlos, IdISSC, Madrid, Spain.
Bergamaschi R; National Neurological Institute C. Mondino, Pavia, Italy.
Hupperts R; Orbis Medical Center, Sittard, the Netherlands.
Grand'Maison F; Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada.
Pucci E; Ospedale di Macerata, Macerata, Italy.
Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Boz C; Karadeniz Technical University, Trabzon, Turkey.
Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
Fernandez-Bolanos R; Hospital Universitario Virgen de Valme, Seville, Spain.
Flechter S; Assaf Harofeh Medical Center, Beer-Yaakov, Israel.
Spitaleri D; AORN San Giuseppe Moscati, Avellino, Italy.
Cristiano E; Hospital Italiano, Buenos Aires, Argentina.
Verheul F; Groen Hart Ziekenhuis, Gouda, the Netherlands.
Lechner-Scott J; John Hunter Hospital, Newcastle, Australia.
Amato MP; Department NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Cabrera-Gomez JA; Centro Internacional de Restauracion Neurologica, Havana, Cuba.
Saladino ML; INEBA, Buenos Aires, Argentina.
Slee M; Flinders University and Medical Centre, Adelaide, Australia.
Moore F; Jewish General Hospital, Montreal, Canada.
Gray O; Craigavon Area Hospital, Portadown, UK.
Paine M; St Vincent's Hospital, Melbourne, Australia.
Barnett M; Brain and Mind Research Institute, Sydney, Australia.
Havrdova E; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
Horakova D; Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
Spelman T; Department of Medicine, University of Melbourne, Melbourne, Australia and Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy/These authors contributed equally to the manuscript.
Butzkueven H; Department of Medicine, University of Melbourne, Melbourne, Australia, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia, and Department of Neurology, Box Hill Hospital, Monash University, Box Hill, Australia.
Pokaż więcej
Corporate Authors :
MSBase Study Group
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2015 Aug; Vol. 21 (9), pp. 1159-71. Date of Electronic Publication: 2014 Dec 05.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Glatiramer Acetate/*therapeutic use
Immunologic Factors/*therapeutic use
Interferon-beta/*therapeutic use
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Humans ; Registries ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies